retatrutide expanded access compassionate use eli lilly Lilly's New Weight-Loss Treatment Shows Promising Results!! Retatrutide, designed to be taken once a week, met the primary endpoint in a phase 3 clinical. The initial TRIUMPH Phase 3 clinical development White House officials on Tuesday

Sleep, nutrition, training load, and metabolic health all influence recovery outcomes

I REGISTER Beauty tips Find all our news, articles and beauty tips for black and mixed-race women

Eloralintide acts in the brain to regulate appetite, slows gastric emptying, and helps metabolism

Clinical trials (STEP 14) showed average weight loss of 1517% body weight over 68 weeks more than twice the average seen with lifestyle modification alone

Possible Side Effects and When to Seek Medical Advice Retatrutide commonly causes gastrointestinal effects such as nausea, vomiting, and diarrhoea, especially during dose escalation

To view or add a comment, sign in Researchers successfully converted a kidney from blood type A to universal type O and transplanted it into a brain-dead person, marking a major step toward expanding access to donor organs